首页> 外文期刊>Basic & clinical pharmacology & toxicology. >The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
【24h】

The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.

机译:广谱阳离子通道阻断剂pinokalant(LOE 908 MS)减少了大鼠的脑梗塞体积:一项温度控制的组织学研究。

获取原文
获取原文并翻译 | 示例
       

摘要

Activation of cation channels conducting Ca2+, Na+ and K+ is involved in the pathogenesis of infarction in experimental focal cerebral ischaemia. Pinokalant (LOE 908 MS) is a novel broad-spectrum inhibitor of several subtypes of such channels and has previously been shown to improve the metabolic and electrophysiologic status of the ischemic penumbra and to reduce lesion size on magnetic resonance images in the acute phase following middle cerebral artery occlusion in rats. The purpose of the present study was to investigate whether these beneficial effects of pinokalant are translated into permanent neuroprotection in terms of a reduction in infarct size one week after middle cerebral artery occlusion in rats. Halothane-anaesthetized male Wistar rats subjected to permanent distal middle cerebral artery occlusion were randomly assigned to one of two treatment groups: 1) Control (vehicle intravenous loading dose followed by infusion); 2) Pinokalant (0.5 mg/kg intravenous loading dose followed by infusion of 1.25 mg/kg/hr). Infusions started 30 min. after middle cerebral artery occlusion and were continued for 24 hr. Body temperature and mean arterial blood pressure were monitored by telemetry during this period and the spontaneous temperature after course in control rats established in other experiments was imitated. Seven days later histological brain sections were prepared and the infarct volumes measured. Body temperature did not differ between the groups. Mean arterial blood pressure was slightly higher in the pinokalant group. Pinokalant treatment significantly reduced cortical infarct volume from 33.8+/-15.8 mm3 to 24.5+/-13.1 mm3 (control group versus pinokalant group, P=0.017, t-test). Taking the effective drug plasma concentration established in other experiments into account revealed that in rats with plasma concentrations within the therapeutic interval, infarct volumes were further reduced to 17.9+/-7.5 mm3 (P<0.005).
机译:阳离子Ca2 +,Na +和K +的阳离子通道的激活与实验性局灶性脑缺血的梗死发病机制有关。 Pinokalant(LOE 908 MS)是这种通道的几种亚型的新型广谱抑制剂,先前已被证明可以改善缺血性半影​​的代谢和电生理状态,并减少中间阶段后急性期磁共振图像上的病变大小大鼠脑动脉闭塞。本研究的目的是调查大鼠大脑中动脉闭塞一周后梗死面积的缩小是否能将pinokalant的这些有益作用转化为永久性神经保护作用。氟烷麻醉的雄性Wistar大鼠经永久性远端大脑中动脉闭塞后,随机分为两个治疗组之一:1)对照组(车辆静脉内负荷剂量,然后输注); 2)Pinokalant(0.5 mg / kg静脉内负荷剂量,然后输注1.25 mg / kg / hr)。开始输注30分钟。在大脑中动脉闭塞后继续进行24小时。在此期间,通过遥测法监测体温和平均动脉血压,并模仿在其他实验中建立的对照组大鼠的自发体温。 7天后,准备组织学脑切片并测量梗塞体积。两组之间的体温没有差异。 Pinokalant组的平均动脉血压略高。 Pinokalant治疗可将皮质梗死体积从33.8 +/- 15.8 mm3显着降低至24.5 +/- 13.1 mm3(对照组与pinokalant组,P = 0.017,t检验)。考虑到在其他实验中确定的有效药物血浆浓度后发现,在血浆浓度在治疗间隔内的大鼠中,梗塞体积进一步减小至17.9 +/- 7.5 mm3(P <0.005)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号